References
Products Transfection
Free Sample Offer
Instruction for Use:
In the „Transfection Reagent Selection Guide“ you can find existing references by setting different filters e.g. for your combination of nucleic acid and cell type. Appropriate keywords in the “Search references“ at the top of the page can also yield a result. A reference indicates that the found transfection reagent has been successfully used for the corresponding application. Ideally, tested transfection parameters and transfection efficiencies are specified.
No reference? > General Selection Guide
If the list does not include a reference concerning your cell type, this does not mean that there is no suitable reagent available, but only that there is no report of experiences with this cell type. In this case it is necessary to preselect (General Selection Guide) and test a reagent (Free Sample Offer). If you want to write an application note for us we will make you an Offer for consideration.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVLC2 |
Human umbilical vein endothelial cells | Human | vasculature | unknown | adherent | plasmid | Metafectene PRO | application note | ![]() |
||||
hAEC |
Human aortic endothelial cells | Human | vasculature | unknown | adherent | plasmid | Metafectene PRO | application note | ![]() |
||||
hASMC |
Human arterial smooth muscle cells | Human | vasculature | unknown | siRNA | RNA-Interference | Metafectene SI | publication | M. R. Schroeter et al., Cardiovasc Res, Aug 2013; 99: 555 - 565 | Link | |||
HMEC-1 |
Human dermal microvascular endothelial cells | ATCC CRL-3243 | Human | vasculature | cell line | adherent | plasmid | Metafectene PRO | publication | D. Flügel et al., Blood, 2012, 119(5):1292‐1301, doi:10.1182/blood-2011-08-375014 | Link | ||
HMEC-1 |
Human dermal microvascular endothelial cells | ATCC CRL-3243 | Human | vasculature | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | D. Flügel et al., Blood, 2012, 119(5):1292‐1301, doi:10.1182/blood-2011-08-375014 | Link | |
hMVEC |
Human microvascular endothelial cells | Human | vasculature | unknown | plasmid | Metafectene PRO | publication | G. Tabatabai et al., Brain, Oct 2008; 131: 2579 - 2595 | Link | ||||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | plasmid | Metafectene PRO | publication | S.-W. Lee et al., Molecular Therapy, 2013, 21 (9): 1767–1777, doi:10.1038/mt.2013.146 | Link | ||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | oligonucleotide | DOTAP | publication | A. Avinó et al., Protocols in Nucleic Acid Chemistry, 2020, 77: e78, doi: 10.1002/cpnc.78 | |||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | plasmid | Metafectene PRO | publication | S. Bellou et al., Am J Physiol Cell Physiol, Dec 2009; 297: C1477 - C1489 | |||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | oligonucleotide | Metafectene | application note | ![]() |
|||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S.-W. Lee et al., Molecular Therapy, 2013, 21 (9): 1767–1777, doi:10.1038/mt.2013.146 | Link | |
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | plasmid | Metafectene PRO | publication | S. Zografou et al., J. Cell Sci., Oct 2012; 125: 4780 - 4790 | Link | ||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | J. Park et al., Biochem. and Biophys. Res. Commun., 2018, 495: 2050e2057 | ||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | H.-Y. Lee et al., Korean Circ. J., 2012, 42: 239-245, doi.org/10.4070/kcj.2012.42.4.239 | Link | |
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | plasmid | Metafectene PRO | publication | N. Kostopoulou et al., J. Cell Sci., 2021, 134, jcs246892, doi:10.1242/jcs.246892 | Link | ||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | oligonucleotide | Metafectene | publication | A. H. Wagner et al., Arterioscler Thromb Vasc Biol, Nov 2009; 29: 1894 - 1901 | Link | ||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | plasmid | Metafectene PRO | publication | J. Yang et al., Oncology Reports, 2015, 34: 2745-2751; DOI: 10.3892/or.2015.4223 | Link | ||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | H.-Y. Lee et al., Cardiovasc Res, Jan 2013; 97: 143 - 152 | ||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | S. Thakker et al., Oncotarget, 2018, 9 (1): 1210-1228 | Link | |
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | J. Park et al., Biochem. and Biophys. Res. Commun., 2018, 495: 2050-2057, doi.org/10.1016/j.bbrc.2017.08.023 | ||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | siRNA | RNA-Interference | Metafectene | publication | A. Giordano et al., Am J Physiol Heart Circ Physiol, Jan 2012; 302: H135 - H142 | Link | |
hVSMC |
Human vascular (aortic) smooth muscle cells | Human | vasculature | unknown | adherent | siRNA | RNA-Interference | Metafectene | publication | A. Giordano et al., Cardiovasc Res, Aug 2008; 79: 519 - 526 | Link | ||
hVSMC |
Human primary vascular smooth muscle cells | Human | vasculature | primary cell | adherent | plasmid | stable transfection | Metafectene | publication | G. Weisinger et al., Exp. Cell Res., 2013, 319: 1586-1593, doi.org/10.1016/j.yexcr.2013.04.001 | |||
MOVAS-1 |
Mouse aorta smooth muscle cells | ATCC CRL-2797 | Mouse | vasculature | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | B. Park et al., Bioscience, Biotechnology, and Biochemistry, 2015, 79(4): 539-552; DOI: 10.1080/09168451.2014.991681 | Link | |
MOVAS-1 |
Mouse aorta smooth muscle cells | ATCC CRL-2797 | Mouse | vasculature | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | K. Lee et al., Arch. Pharm. Res., 2016, 39:83-93; DOI 10.1007/s12272-015-0687-3 |